Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events

Snus use at admission for a first PCI was not associated with a higher occurrence of all-cause mortality, new revascularisation or heart failure hospitalisation. Discontinuing snus after a first PCI was associated with a significantly longer duration to a subsequent PCI.